The University of Chicago Header Logo

Connection

James Vardiman to Receptors, Interleukin-2

This is a "connection" page, showing publications James Vardiman has written about Receptors, Interleukin-2.
Connection Strength

0.043
  1. Serum soluble interleukin-2 receptor is associated with clinical and pathologic disease status in hairy cell leukemia. Blood. 1990 Nov 15; 76(10):1941-5.
    View in: PubMed
    Score: 0.023
  2. Diagnostic criteria and classification of mastocytosis: a consensus proposal. Leuk Res. 2001 Jul; 25(7):603-25.
    View in: PubMed
    Score: 0.012
  3. Phase I trial of a genetically engineered interleukin-2 fusion toxin (DAB486IL-2) as a 6 hour intravenous infusion in patients with hematologic malignancies. Leuk Lymphoma. 1994 Jul; 14(3-4):257-62.
    View in: PubMed
    Score: 0.007
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.